Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ALTRIA GROUP, INC.MO · Entity 188 | Director | May 20, 2021 | May 24, 2021 |
| Chemours CoCC · Entity 4420 | Director · President and CEO | June 09, 2023 | June 12, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ALTRIA GROUP, INC.
Report date May 20, 2021 · Filed May 24, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,604 |
Reported balance
After 2021-05-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-05-20 · Grant · Acquired 3,517 · Balance 22,604 F1: Deferred stock awarded under the 2015 Stock Compensation Plan for Non-Employee Directors. F2: Includes 16,582 deferred shares held under the Stock Compensation Plan for Non-Employee Directors, including an increase of 1,007 shares acquired through the reinvestment of dividends and one share as a result of the accumulation of fractional shares since May 14, 2020, the date of the last reportable transaction. |
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,685 |
Reported balance
Holding disclosure · report date 2021-05-20 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 2,685 F3: Phantom stock units convert to the cash value of the issuer's common stock on a 1-for-1 basis. F4: The participant will receive distributions of phantom stock units in cash either prior to or following termination of service as a member of the issuer's board of directors, as elected by the participant. F5: Share equivalents held in the Deferred Fee Plan for Non-Employee Directors. This total includes 207 share equivalents acquired through the reinvestment of dividends since May 14, 2020, the date of the last reportable transaction. |
Filing footnotes · ownership attribution and instrument terms
F1: Deferred stock awarded under the 2015 Stock Compensation Plan for Non-Employee Directors.
F2: Includes 16,582 deferred shares held under the Stock Compensation Plan for Non-Employee Directors, including an increase of 1,007 shares acquired through the reinvestment of dividends and one share as a result of the accumulation of fractional shares since May 14, 2020, the date of the last reportable transaction.
F3: Phantom stock units convert to the cash value of the issuer's common stock on a 1-for-1 basis.
F4: The participant will receive distributions of phantom stock units in cash either prior to or following termination of service as a member of the issuer's board of directors, as elected by the participant.
F5: Share equivalents held in the Deferred Fee Plan for Non-Employee Directors. This total includes 207 share equivalents acquired through the reinvestment of dividends since May 14, 2020, the date of the last reportable transaction.
Chemours Co
Report date June 09, 2023 · Filed June 12, 2023 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 266,954.5706 |
Reported balance
After 2023-06-09 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2023-06-09 · Purchase · Acquired 7,661 · Balance 266,954.5706 F1: The original Form 4, filed on June 12, 2023, is amended by this Form 4 amendment solely to correct the price of reported stock purchased. F2: Includes directly owned shares, restricted stock units and dividend equivalent units. |
| Common StockSEC Table I · non-derivative | IndirectReporting person's children | 2,480 |
Reported balance
Holding disclosure · report date 2023-06-09 · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · Balance 2,480 |
| Common StockSEC Table I · non-derivative | IndirectBy GRAT | 32,155 |
Reported balance
Holding disclosure · report date 2023-06-09 · row 3
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 3 · Balance 32,155 |
Filing footnotes · ownership attribution and instrument terms
F1: The original Form 4, filed on June 12, 2023, is amended by this Form 4 amendment solely to correct the price of reported stock purchased.
F2: Includes directly owned shares, restricted stock units and dividend equivalent units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2019 Filed Feb 20, 2019 20:53 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 195,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-19-000003 · primary_doc.xml · nonDerivative · entry 1 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,160 F1 · shares: Vesting of performance share units (PSUs). Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 20:37 UTC | ALTRIA GROUP, INC. MO · Entity 188 | GrantPhantom Stock Units · Derivative | 281 | $49.00 | $13,767.60 |
DisclosureSEC source: 0001182489-19-000008 · edgar.xml · derivative · entry 2 Newman Mark · CIK 0001524597 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 999 Underlying: Common Stock · 281 shares Expires not disclosed F2 · derivative.exercise_price: Phantom stock units convert to the cash value of the issuer's common stock on a 1-for-1 basis. F3 · shares: These units were acquired on December 31, 2018 pursuant to the Deferred Fee Plan for Non-Employee Directors. F5 · price: The average of the high and low price of Altria Group, Inc. common stock on December 31, 2018. F4 · derivative.exercise_date: The participant will receive distributions of phantom stock units in cash either prior to or following termination of service as a member of the issuer's board of directors, as elected by the participant. F4 · derivative.expiration_date: The participant will receive distributions of phantom stock units in cash either prior to or following termination of service as a member of the issuer's board of directors, as elected by the participant. F6 · balance_after: Share equivalents held in the Deferred Fee Plan for Non-Employee Directors. This total includes the December 31, 2018 acquisition of 281 share equivalents under the Deferred Fee Plan for Non-Employee Directors and 9 share equivalents acquired through the reinvestment of dividends since September 28, 2018, the date of the last reportable transaction. Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 18:12 UTC | ALTRIA GROUP, INC. MO · Entity 188 | GrantPhantom Stock Units · Derivative | 227 | $60.62 | $13,759.61 |
DisclosureSEC source: 0001182489-18-000427 · edgar.xml · derivative · entry 2 Newman Mark · CIK 0001524597 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 709 Underlying: Common Stock · 227 shares Expires not disclosed F2 · derivative.exercise_price: Phantom stock units convert to the cash value of the issuer's common stock on a 1-for-1 basis. F3 · shares: These units were acquired on September 28, 2018 pursuant to the Deferred Fee Plan for Non-Employee Directors. F5 · price: The average of the high and low price of Altria Group, Inc. common stock on September 28, 2018. F4 · derivative.exercise_date: The participant will receive distributions of phantom stock units in cash either prior to or following termination of service as a member of the issuer's board of directors, as elected by the participant. F4 · derivative.expiration_date: The participant will receive distributions of phantom stock units in cash either prior to or following termination of service as a member of the issuer's board of directors, as elected by the participant. F6 · balance_after: Share equivalents held in the Deferred Fee Plan for Non-Employee Directors. This total includes the September 28, 2018 acquisition of 227 share equivalents under the Deferred Fee Plan for Non-Employee Directors and 6 share equivalents acquired through the reinvestment of dividends since June 29, 2018, the date of the last reportable transaction. Read SEC document |
| August 04, 2018 Filed Aug 7, 2018 20:47 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 30,806 | $47.04 | $1,449,114.24 |
DisclosureSEC source: 0001627223-18-000036 · primary_doc.xml · nonDerivative · entry 1 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,341 F1 · shares: Shares withheld for tax obligations on vesting restricted stock units and dividend equivalent units. No shares were sold. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 19:39 UTC | ALTRIA GROUP, INC. MO · Entity 188 | GrantPhantom Stock Units · Derivative | 241 | $57.10 | $13,761.10 |
DisclosureSEC source: 0001182489-18-000303 · edgar.xml · derivative · entry 2 Newman Mark · CIK 0001524597 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 476 Underlying: Common Stock · 241 shares Expires not disclosed F2 · derivative.exercise_price: Phantom stock units convert to the cash value of the issuer's common stock on a 1-for-1 basis. F3 · shares: These units were acquired on June 29, 2018 pursuant to the Deferred Fee Plan for Non-Employee Directors. F5 · price: The average of the high and low price of Altria Group, Inc. common stock on June 29, 2018. F4 · derivative.exercise_date: The participant will receive distributions of phantom stock units in cash either prior to or following termination of service as a member of the issuer's board of directors, as elected by the participant. F4 · derivative.expiration_date: The participant will receive distributions of phantom stock units in cash either prior to or following termination of service as a member of the issuer's board of directors, as elected by the participant. F6 · balance_after: Share equivalents held in the Deferred Fee Plan for Non-Employee Directors. This total includes the June 29, 2018 acquisition of 241 share equivalents under the Deferred Fee Plan for Non-Employee Directors since May 17, 2018, the date of the last reportable transaction. Read SEC document |
| May 17, 2018 Filed May 21, 2018 19:53 UTC | ALTRIA GROUP, INC. MO · Entity 188 | GrantPhantom Stock Units · Derivative | 90 | $55.30 | $4,977.00 |
DisclosureSEC source: 0001182489-18-000237 · edgar.xml · derivative · entry 2 Newman Mark · CIK 0001524597 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235 Underlying: Common Stock · 90 shares Expires not disclosed F3 · derivative.exercise_price: Phantom stock units convert to the cash value of the issuer's common stock on a 1-for-1 basis. F4 · shares: These units were acquired on May 17, 2018 pursuant to the Deferred Fee Plan for Non-Employee Directors. F6 · price: The average of the high and low price of Altria Group, Inc. common stock on May 17, 2018. F5 · derivative.exercise_date: The participant will receive distributions of phantom stock units in cash either prior to or following termination of service as a member of the issuer's board of directors, as elected by the participant. F5 · derivative.expiration_date: The participant will receive distributions of phantom stock units in cash either prior to or following termination of service as a member of the issuer's board of directors, as elected by the participant. F7 · balance_after: Share equivalents held in the Deferred Fee Plan for Non-Employee Directors. Read SEC document |
| May 17, 2018 Filed May 21, 2018 19:53 UTC | ALTRIA GROUP, INC. MO · Entity 188 | GrantCommon Stock | 3,165 | $0.00 | $0.00 |
DisclosureSEC source: 0001182489-18-000237 · edgar.xml · nonDerivative · entry 1 Newman Mark · CIK 0001524597 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,187 F1 · shares: Deferred stock awarded under the 2015 Stock Compensation Plan for Non-Employee Directors. F2 · balance_after: Includes 3,165 deferred shares held in the Stock Compensation Plan for Non-Employee Directors. Read SEC document |
| May 08, 2018 Filed May 10, 2018 21:02 UTC | Chemours Co CC · Entity 4420 | Exercise / conversionStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $18.45 | $0.00 |
DisclosureSEC source: 0001627223-18-000031 · primary_doc.xml · derivative · entry 5 Newman Mark · CIK 0001524597 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,675 Underlying: Common Stock · 40,000 shares Expires 2022-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F4 · derivative.exercise_date: Option award was granted on February 4, 2015 with vesting in three equal annual installments beginning February 4, 2016. Read SEC document |
| May 08, 2018 Filed May 10, 2018 21:02 UTC | Chemours Co CC · Entity 4420 | SaleCommon Stock | 3,675 | $50.45 | $185,403.75 |
DisclosureSEC source: 0001627223-18-000031 · primary_doc.xml · nonDerivative · entry 3 Newman Mark · CIK 0001524597 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,724 F1 · kind: The stock option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F2 · price: Price reported is a weighted average. Shares were sold in multiple transactions at prices ranging from $50.00 to $50.81. F3 · balance_after: Includes restricted stock units and dividend equivalent units. Read SEC document |
| May 08, 2018 Filed May 10, 2018 21:02 UTC | Chemours Co CC · Entity 4420 | SaleCommon Stock | 40,000 | $50.00 | $2,000,000.00 |
DisclosureSEC source: 0001627223-18-000031 · primary_doc.xml · nonDerivative · entry 2 Newman Mark · CIK 0001524597 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,399 F1 · kind: The stock option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. Read SEC document |
| May 08, 2018 Filed May 10, 2018 21:02 UTC | Chemours Co CC · Entity 4420 | Exercise / conversionCommon Stock | 40,000 | $18.45 | $738,000.00 |
DisclosureSEC source: 0001627223-18-000031 · primary_doc.xml · nonDerivative · entry 1 Newman Mark · CIK 0001524597 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,399 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. Read SEC document |
| April 30, 2018 Filed May 2, 2018 19:40 UTC | ALTRIA GROUP, INC. MO · Entity 188 | OtherPhantom Stock Units · Derivative | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001182489-18-000203 · edgar.xml · derivative · entry 2 Newman Mark · CIK 0001524597 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145 Underlying: Common Stock · 0 shares Expires not disclosed F2 · derivative.exercise_price: Phantom stock units convert to the cash value of the issuer's common stock on a 1-for-1 basis. F3 · shares: No share equivalents acquired or disposed. F4 · derivative.exercise_date: The participant will receive distributions of phantom stock units in cash either prior to or following termination of service as a member of the issuer's board of directors, as elected by the participant. F4 · derivative.expiration_date: The participant will receive distributions of phantom stock units in cash either prior to or following termination of service as a member of the issuer's board of directors, as elected by the participant. F5 · balance_after: Share equivalents held in the Deferred Fee Plan for Non-Employee Directors. This includes an increase of one share equivalent acquired through the reinvestment of dividends since March 30, 2018, the date of the last reportable transaction. Read SEC document |
| April 30, 2018 Filed May 2, 2018 19:40 UTC | ALTRIA GROUP, INC. MO · Entity 188 | PurchaseCommon Stock | 5,345 | $56.19 | $300,334.48 |
DisclosureSEC source: 0001182489-18-000203 · edgar.xml · nonDerivative · entry 1 Newman Mark · CIK 0001524597 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,022 F1 · price: The price reported in Column 4 is a weighted average price of all shares purchased. The shares were purchased in multiple transactions at prices ranging from $56.1475 to $56.1932. The reporting person undertakes to provide to Altria Group, Inc., any security holder of Altria Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote 1 to this Form 4. Read SEC document |
| March 30, 2018 Filed Apr 3, 2018 19:50 UTC | ALTRIA GROUP, INC. MO · Entity 188 | GrantPhantom Stock Units · Derivative | 144 | $62.66 | $9,022.32 |
DisclosureSEC source: 0001182489-18-000188 · edgar.xml · derivative · entry 2 Newman Mark · CIK 0001524597 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144 Underlying: Common Stock · 144 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units convert to the cash value of the issuer's common stock on a 1-for-1 basis. F2 · shares: These units were acquired on March 30, 2018 pursuant to the Deferred Fee Plan for Non-Employee Directors. F4 · price: The average of the high and low price of Altria Group, Inc. common stock on March 29, 2018 (as the NYSE was closed for a holiday on March 30, 2018). F3 · derivative.exercise_date: The participant will receive distributions of phantom stock units in cash either prior to or following termination of service as a member of the issuer's board of directors, as elected by the participant. F3 · derivative.expiration_date: The participant will receive distributions of phantom stock units in cash either prior to or following termination of service as a member of the issuer's board of directors, as elected by the participant. F5 · balance_after: Share equivalents held in the Deferred Fee Plan for Non-Employee Directors. Read SEC document |
| March 09, 2018 Filed Mar 9, 2018 21:58 UTC | Chemours Co CC · Entity 4420 | SaleCommon Stock | 700 | $49.00 | $34,300.00 |
DisclosureSEC source: 0001627223-18-000018 · primary_doc.xml · nonDerivative · entry 7 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · Reporting person's children Disclosed balance after: 2,480 F2 · kind: Shares subject to this transaction are owned by the reporting person's children. The reporting person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that he is the beneficial owner of the shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 09, 2018 Filed Mar 9, 2018 21:58 UTC | Chemours Co CC · Entity 4420 | SaleCommon Stock | 800 | $49.05 | $39,236.00 |
DisclosureSEC source: 0001627223-18-000018 · primary_doc.xml · nonDerivative · entry 6 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · Reporting person's children Disclosed balance after: 3,180 F2 · kind: Shares subject to this transaction are owned by the reporting person's children. The reporting person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that he is the beneficial owner of the shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 09, 2018 Filed Mar 9, 2018 21:58 UTC | Chemours Co CC · Entity 4420 | SaleCommon Stock | 10,600 | $49.13 | $520,820.40 |
DisclosureSEC source: 0001627223-18-000018 · primary_doc.xml · nonDerivative · entry 5 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,399 F1 · balance_after: Includes restricted stock units (RSUs) and dividend equivalent units (DEUs). Read SEC document |
| March 09, 2018 Filed Mar 9, 2018 21:58 UTC | Chemours Co CC · Entity 4420 | SaleCommon Stock | 17,281 | $49.24 | $850,906.07 |
DisclosureSEC source: 0001627223-18-000018 · primary_doc.xml · nonDerivative · entry 4 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,999 F1 · balance_after: Includes restricted stock units (RSUs) and dividend equivalent units (DEUs). Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 08:16 UTC Amendment | Chemours Co CC · Entity 4420 | SaleCommon Stock | 700 | $49.00 | $34,300.00 |
DisclosureSEC source: 0001627223-18-000019 · primary_doc.xml · nonDerivative · entry 7 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · Reporting person's children Disclosed balance after: 2,480 F2 · kind: Shares subject to this transaction are owned by the reporting person's children. The reporting person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that he is the beneficial owner of the shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 08:16 UTC Amendment | Chemours Co CC · Entity 4420 | SaleCommon Stock | 800 | $49.05 | $39,236.00 |
DisclosureSEC source: 0001627223-18-000019 · primary_doc.xml · nonDerivative · entry 6 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · Reporting person's children Disclosed balance after: 3,180 F2 · kind: Shares subject to this transaction are owned by the reporting person's children. The reporting person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that he is the beneficial owner of the shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 08:16 UTC Amendment | Chemours Co CC · Entity 4420 | SaleCommon Stock | 10,600 | $49.13 | $520,820.40 |
DisclosureSEC source: 0001627223-18-000019 · primary_doc.xml · nonDerivative · entry 5 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,399 F1 · balance_after: Includes restricted stock units (RSUs) and dividend equivalent units (DEUs). Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 08:16 UTC Amendment | Chemours Co CC · Entity 4420 | SaleCommon Stock | 17,281 | $49.24 | $850,906.07 |
DisclosureSEC source: 0001627223-18-000019 · primary_doc.xml · nonDerivative · entry 4 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,999 F1 · balance_after: Includes restricted stock units (RSUs) and dividend equivalent units (DEUs). Read SEC document |
| March 07, 2018 Filed Mar 9, 2018 21:58 UTC | Chemours Co CC · Entity 4420 | GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-18-000018 · primary_doc.xml · nonDerivative · entry 3 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,999 F1 · balance_after: Includes restricted stock units (RSUs) and dividend equivalent units (DEUs). Read SEC document |
| March 07, 2018 Filed Mar 9, 2018 21:58 UTC | Chemours Co CC · Entity 4420 | GiftCommon Stock | 1,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-18-000018 · primary_doc.xml · nonDerivative · entry 2 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · Reporting person's children Disclosed balance after: 3,980 F2 · kind: Shares subject to this transaction are owned by the reporting person's children. The reporting person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that he is the beneficial owner of the shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 07, 2018 Filed Mar 9, 2018 21:58 UTC | Chemours Co CC · Entity 4420 | GiftCommon Stock | 1,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-18-000018 · primary_doc.xml · nonDerivative · entry 1 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,179 F1 · balance_after: Includes restricted stock units (RSUs) and dividend equivalent units (DEUs). Read SEC document |
| March 07, 2018 Filed Mar 12, 2018 08:16 UTC Amendment | Chemours Co CC · Entity 4420 | GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-18-000019 · primary_doc.xml · nonDerivative · entry 3 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,280 F1 · balance_after: Includes restricted stock units (RSUs) and dividend equivalent units (DEUs). Read SEC document |
| March 07, 2018 Filed Mar 12, 2018 08:16 UTC Amendment | Chemours Co CC · Entity 4420 | GiftCommon Stock | 1,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-18-000019 · primary_doc.xml · nonDerivative · entry 2 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · Reporting person's children Disclosed balance after: 3,980 F2 · kind: Shares subject to this transaction are owned by the reporting person's children. The reporting person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that he is the beneficial owner of the shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 07, 2018 Filed Mar 12, 2018 08:16 UTC Amendment | Chemours Co CC · Entity 4420 | GiftCommon Stock | 1,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-18-000019 · primary_doc.xml · nonDerivative · entry 1 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,280 F1 · balance_after: Includes restricted stock units (RSUs) and dividend equivalent units (DEUs). Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 20:26 UTC | Chemours Co CC · Entity 4420 | GrantStock Option (Right to Buy) · Derivative | 23,357 | $0.00 Strike: $48.53 | $0.00 |
DisclosureSEC source: 0001627223-18-000011 · primary_doc.xml · derivative · entry 1 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,357 Underlying: Common Stock · 23,357 shares Expires 2028-03-01 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on March 1, 2019. Read SEC document |
| February 04, 2018 Filed Feb 6, 2018 20:42 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 2,231 | $49.22 | $109,809.82 |
DisclosureSEC source: 0001627223-18-000002 · primary_doc.xml · nonDerivative · entry 1 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,460 F1 · shares: Shares withheld for tax obligations on vesting restricted stock units (RSUs) and dividend equivalent units (DEUs). No shares were sold. F2 · balance_after: Includes directly owned shares, unvested RSUs and DEUs. Read SEC document |
| November 10, 2017 Filed Nov 14, 2017 21:40 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 14,716 | $50.07 | $736,830.12 |
DisclosureSEC source: 0001627223-17-000060 · primary_doc.xml · nonDerivative · entry 1 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,650 F1 · shares: Shares withheld for tax obligations on restricted stock units (RSUs) and dividend equivalent units (DEUs). No shares were sold. F2 · balance_after: Includes directly owned shares, unvested RSUs and DEUs. Read SEC document |
| May 05, 2017 Filed May 5, 2017 21:59 UTC | Chemours Co CC · Entity 4420 | SaleCommon Stock | 350 | $40.79 | $14,276.50 |
DisclosureSEC source: 0001627223-17-000039 · primary_doc.xml · nonDerivative · entry 5 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · Reporting person's children Disclosed balance after: 2,800 Read SEC document |
| May 04, 2017 Filed May 5, 2017 21:59 UTC | Chemours Co CC · Entity 4420 | GiftCommon Stock | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-17-000039 · primary_doc.xml · nonDerivative · entry 4 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · Reporting person's children Disclosed balance after: 3,150 F3 · kind: This transaction involved a gift of securities by the reporting person to one of his children. The reporting person disclaims beneficial ownership of the shares held by his children, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| May 04, 2017 Filed May 5, 2017 21:59 UTC | Chemours Co CC · Entity 4420 | GiftCommon Stock | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-17-000039 · primary_doc.xml · nonDerivative · entry 3 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,145 F3 · kind: This transaction involved a gift of securities by the reporting person to one of his children. The reporting person disclaims beneficial ownership of the shares held by his children, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or for any other purpose. F2 · balance_after: Includes directly owned shares, unvested restricted stock units and dividend equivalent units. Read SEC document |
| May 04, 2017 Filed May 5, 2017 21:59 UTC | Chemours Co CC · Entity 4420 | GiftCommon Stock | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-17-000039 · primary_doc.xml · nonDerivative · entry 2 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,495 F2 · balance_after: Includes directly owned shares, unvested restricted stock units and dividend equivalent units. Read SEC document |
| May 04, 2017 Filed May 5, 2017 21:59 UTC | Chemours Co CC · Entity 4420 | SaleCommon Stock | 22,431 | $39.82 | $893,202.42 |
DisclosureSEC source: 0001627223-17-000039 · primary_doc.xml · nonDerivative · entry 1 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,120 F1 · price: Price reported is a weighted average. Shares were sold in multiple transactions at prices ranging from $39.92 to $39.71. F2 · balance_after: Includes directly owned shares, unvested restricted stock units and dividend equivalent units. Read SEC document |
| March 09, 2017 Filed Mar 10, 2017 20:02 UTC | Chemours Co CC · Entity 4420 | GrantStock Option (Right to Buy) · Derivative | 31,662 | $0.00 Strike: $34.72 | $0.00 |
DisclosureSEC source: 0001627223-17-000021 · primary_doc.xml · derivative · entry 1 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,662 Underlying: Common Stock · 31,662 shares Expires 2027-02-28 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on March 1, 2018. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 20:47 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 61,194 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-17-000012 · primary_doc.xml · nonDerivative · entry 1 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,551 F1 · shares: Performance-based restricted stock units that vest on August 4, 2018. F2 · balance_after: Includes directly owned shares, unvested restricted stock units and dividend equivalent units. Read SEC document |
| February 04, 2017 Filed Feb 7, 2017 20:33 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 2,492 | $27.62 | $68,829.04 |
DisclosureSEC source: 0001627223-17-000004 · primary_doc.xml · nonDerivative · entry 1 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,356 F1 · shares: Shares withheld for tax obligations on vested restricted stock units (RSUs) and dividend equivalent units (DEUs). No shares were sold. F2 · balance_after: Includes directly owned shares, unvested RSUs and DEUs. Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 21:47 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 10,544 | $20.71 | $218,366.24 |
DisclosureSEC source: 0001627223-16-000149 · primary_doc.xml · nonDerivative · entry 1 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,738 F1 · shares: Taxes withheld on vested restricted stock units and dividend equivalent units. F2 · balance_after: Includes directly owned shares, unvested restricted stock units and dividend equivalent units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.